Class of severely disabled Medicaid recipients challenged Florida’s decision to deny coverage of a prescription drug, Neurontin, for medically accepted indications that were cited in congressionally-recognized drug compendia, including neuropathic pain and certain psychiatric disorders, in violation of the Medicaid Act.
The Pennsylvania Insurance Department solicited public comments as it considers updating the commonwealth's Essential Health Benefits (EHB) benchmark plan.…